Jun 19, 2017 · ... trial powered to assess a range of complex outcomes in both affected participants and their companions. The efficacy of the intervention in ...

... trial powered to assess the intervention's effect on clinical outcomes in larger populations. Conclusions and Future Directions. The findings of this trial ...

What outcomes was the LEADER trial powered to assess? Can you specifically discuss the secondary microvascular outcomes in the kidney?

... trial powered to assess a range of complex outcomes in both affected participants and their companions. The efficacy of the intervention in improving ...

Feb 6, 2024 · ... trial powered to assess the intervention's effect on clinical outcomes in larger populations. Conclusions and Future Directions. The findings ...

Oct 31, 2002 · ... trial powered to assess survival ultimately can answer the important question of the relative efficacy of RP compared with various forms of ...

... trial powered to assess clinical outcomes in AD patients, ALS patients, or both would be warranted. Study Design. Go to sections. Top of Page Study ...

Feb 5, 2010 · ... trial powered to assess the difference in outcomes is required to better understand the functional and morphological outcomes. The rate of ...

Feb 8, 2024 · ... trial powered to assess clinical outcome (pCR). Clinical trial information: NCT04895761. Research Sponsor: IMV INC. BREAST CANCER—METASTATIC.

Oct 9, 2020 · In view of these data, we performed a randomized controlled trial powered to assess the clinical efficacy and safety of DES among patients ...